THERAZONE ApS: Financial statements 2020
CVR: 27255574
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
THERAZONE ApS (CVR 27255574) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -114,816 and a net result of DKK 9,211,677 compared with DKK 7,673,690 the year before. Equity in the 2020 report amounted to DKK 43,522,929. The solvency ratio was 95.3%.
- Gross Profit
- DKK -114,816
- Profit/Loss
- DKK 9,211,677
- Equity
- DKK 43,522,929
- Total Assets
- DKK 45,682,378
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -115 t. | 9.2 mio. | 43.5 mio. | - |
| 2019 | - | 13 t. | 7.7 mio. | 34.4 mio. | - |
| 2018 | - | -221 t. | -233 t. | 26.9 mio. | - |
| 2017 | - | -245 t. | 43.7 mio. | 45.1 mio. | - |
| 2016 | - | 238 t. | 453 t. | 1.3 mio. | - |
Official annual report
How creditworthy is THERAZONE ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
THERAZONE ApS has published its annual report for 2019. Gross profit came to DKK 12,656, and the net result was DKK 7,673,690.
About THERAZONE ApS
THERAZONE ApS is a Danish company of the type Anpartsselskab based in Dragør, founded in 2003. The company is registered under the industry Investering for egen regning. The management consists of Thomas Magnussen. The company is owned by Thomas Magnussen. The company has 2 employees (2026). In 2024, the company reported a gross profit of DKK -255,949 and a net result of DKK 4,003,809 compared with DKK 2,462,806 the year before. Equity in the 2024 report amounted to DKK 44,842,105.